3 results
The objectives of the study are to fine-tune the Xres5 algorithm settings (for cine and fluoroscopy) to optimize the image quality (IQ) and assess and feasibility of using the improved IQ of Xres5 processing to reduce radiation dose or contrast…
Primary Objective: Safety Run-in Period:To evaluate the occurrence of tumor lysis syndrome (TLS) and doselimiting toxicities (DLTs) with the concurrent administration of ibrutinib and venetoclax.Randomization Phase:To evaluate whether the…
Primary ObjectiveThe primary objective of the study is to assess progression-free survival (PFS) from treatment with ibrutinib plus venetoclax (I+VEN) compared with obinutuzumab plus chlorambucil (G-Clb) as assessed by an Independent Review…